+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Testing Market by Drug Testing Product, Sample Type, End-User - Global Forecast 2025-2030- Product Image
Drug Testing Market by Drug Testing Product, Sample Type, End-User - Global Forecast 2025-2030- Product Image
Sale

Drug Testing Market by Drug Testing Product, Sample Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454917
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Testing Market grew from USD 22.25 billion in 2023 to USD 24.94 billion in 2024. It is expected to continue growing at a CAGR of 12.18%, reaching USD 49.76 billion by 2030.

The drug testing market encompasses a wide spectrum of screening methods in medical, employment, sports, and forensic domains. Its scope includes detecting substances such as alcohol, marijuana, opioids, and other drugs in various samples like urine, blood, saliva, and hair. The necessity stems from ensuring workplace safety, compliance with legal regulations, and bolstering public health initiatives. The application spans sectors such as healthcare for monitoring patient adherence, corporate settings for pre-employment and random drug checks, law enforcement, and sports organizations for anti-doping measures. The end-use scope is broad, including laboratories, hospitals, educational institutions, and criminal justice systems. Key growth factors influencing the market include rising substance abuse rates, stringent regulatory requirements, and the increased awareness of drug testing benefits. Technological advancements, such as the development of rapid testing and portable devices, present significant market opportunities. Additionally, the increasing trend towards workplace wellness programs and government initiatives to combat drug abuse further fuels market expansion. However, challenges like privacy concerns, the high cost of advanced testing, and the potential for false positives or negatives are notable market growth limitations. A significant barrier is the evolving nature of synthetic and designer drugs that complicate detection protocols. To capitalize on opportunities, businesses should focus on developing cost-effective, reliable, and rapid testing technologies that cater to emerging drugs. Investing in research and development aimed at enhancing the accuracy and scope of testing panels can open new avenues for market penetration. The market encourages innovations such as integrating AI for predictive analysis and blockchain for ensuring tamper-proof test results. In this dynamic market, stakeholders should prioritize adaptability by complying with regional regulatory evolutions and ensuring data confidentiality to maintain consumer trust and competitive edge.

Understanding Market Dynamics in the Drug Testing Market

The Drug Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing drug & alcohol consumption
    • Stringent government regulations for drug & alcohol testing
    • Surge in regulatory approvals and product & service development
  • Market Restraints
    • Restriction on the drug testing as it is violation of privacy rights in some countries
  • Market Opportunities
    • Development of advanced drug testing solutions
    • Intelligent fingerprint drug testing system
  • Market Challenges
    • Technical problem in interpreting screening tests and social issue

Exploring Porter’s Five Forces for the Drug Testing Market

Porter’s Five Forces framework further strengthens the insights of the Drug Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Testing Market

External macro-environmental factors deeply influence the performance of the Drug Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Testing Market

The Drug Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Testing Market

The Drug Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Testing Market

The Drug Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Legacy Medical Services, LLC., Omega Laboratories, Inc., Quest Diagnostics, Quidel Corporation, Sciteck Clinical Laboratories, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug Testing Product
    • Assay Kits
    • Consumables
    • Drug Screening Services
    • Products
      • Analytical Instruments
        • Breathalyzers
        • Chromatography Instruments
        • Immunoassay Analyzers
      • Calibrators & Controls
      • Rapid Testing Devices
        • Oral Fluid Testing Devices
        • Urine Testing Devices
      • Sample Collection Tubes
  • Sample Type
    • Breath Samples
    • Hair Samples
    • Oral Fluid Samples
    • Urine Samples
  • End-User
    • Criminal Justice Systems & Law Enforcement Agencies
    • Drug Testing Laboratories
    • Drug Treatment Centers
    • Hospitals
    • Individual Users
    • Pain Management Centers
    • Universities
    • Workplace
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing drug & alcohol consumption
5.1.1.2. Stringent government regulations for drug & alcohol testing
5.1.1.3. Surge in regulatory approvals and product & service development
5.1.2. Restraints
5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
5.1.3. Opportunities
5.1.3.1. Development of advanced drug testing solutions
5.1.3.2. Intelligent fingerprint drug testing system
5.1.4. Challenges
5.1.4.1. Technical problem in interpreting screening tests and social issue
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Drug Testing Market, by Drug Testing Product
6.1. Introduction
6.2. Assay Kits
6.3. Consumables
6.4. Drug Screening Services
6.5. Products
6.5.1. Analytical Instruments
6.5.1.1. Breathalyzers
6.5.1.2. Chromatography Instruments
6.5.1.3. Immunoassay Analyzers
6.5.2. Calibrators & Controls
6.5.3. Rapid Testing Devices
6.5.3.1. Oral Fluid Testing Devices
6.5.3.2. Urine Testing Devices
6.5.4. Sample Collection Tubes
7. Drug Testing Market, by Sample Type
7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples
8. Drug Testing Market, by End-User
8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Universities
8.9. Workplace
9. Americas Drug Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Drug Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Drug Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
FIGURE 2. DRUG TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG TESTING MARKET DYNAMICS
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 60. CANADA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. MEXICO DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. CHINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. CHINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. CHINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. CHINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 93. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. INDIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. INDIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. INDIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 98. INDIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 99. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. JAPAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. JAPAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. JAPAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 111. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 112. JAPAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. THAILAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. THAILAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. THAILAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 147. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 148. THAILAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 162. DENMARK DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. DENMARK DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. DENMARK DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. DENMARK DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 166. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. EGYPT DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. EGYPT DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. EGYPT DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. EGYPT DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 172. EGYPT DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EGYPT DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. FINLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 178. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FINLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. FRANCE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. FRANCE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 184. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. ITALY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. ITALY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 200. ITALY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. ITALY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 202. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. NORWAY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 220. NORWAY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. NORWAY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. POLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. POLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 224. POLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. POLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 226. POLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. POLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. QATAR DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. QATAR DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 230. QATAR DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. QATAR DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 232. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 233. QATAR DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 256. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SPAIN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. TURKEY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. TURKEY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 272. TURKEY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. TURKEY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 274. TURKEY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. TURKEY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 289. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Drug Testing Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Legacy Medical Services, LLC.
  • Omega Laboratories, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Sciteck Clinical Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 24.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 49.76 Billion
Compound Annual Growth Rate12.1%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
At-home Drug of Abuse Testing Market by Product, Test Type, Drug, Distribution Channel - Global Forecast 2025-2030 - Product Image

At-home Drug of Abuse Testing Market by Product, Test Type, Drug, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030 - Product Image

Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032 - Product Image

Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032

  • Report
  • 235 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.